Oxford University Hospitals NHS Foundation Trust, Churchill Hospital

Oxford OX3 9DU

2 studies enrolling now · 5 studies all time

What they study most

Acute Myeloid Leukemia, Brain Metastases From HER2 and Breast Cancer, Brain Metastases From Solid Tumors, CNS Metastases, Colorectal Cancer Metastatic, HER2, HER2 + Breast Cancer, HER2 + Gastric Cancer, HER2 Mutation-Related Tumors, HER2-Positive Solid Tumors, HER2-positive Bladder Cancer, HER2-positive Breast Cancer

Studies at this site

• SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma — Recruiting now
• A Phase 1/1b Study of IAM1363 in HER2 Cancers — Recruiting now
• Study of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute Myeloid Leukemia — Stopped early
• Study of Magrolimab Combinations in Participants With Myeloid Malignancies — Stopped early
• Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer — Completed